138 related articles for article (PubMed ID: 27585748)
1. Effects of Acetylcholinesterase Inhibitors on Balance and Gait Functions and Orthostatic Hypotension in Elderly Patients With Alzheimer Disease.
Isik AT; Soysal P; Usarel C
Am J Alzheimers Dis Other Demen; 2016 Nov; 31(7):580-584. PubMed ID: 27585748
[TBL] [Abstract][Full Text] [Related]
2. The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.
Gareri P; Castagna A; Cotroneo AM; Putignano D; Conforti R; Santamaria F; Marino S; Putignano S
J Alzheimers Dis; 2017; 56(2):557-565. PubMed ID: 28035929
[TBL] [Abstract][Full Text] [Related]
3. Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study.
Gareri P; Putignano D; Castagna A; Cotroneo AM; De Palo G; Fabbo A; Forgione L; Giacummo A; Lacava R; Marino S; Simone M; Zurlo A; Putignano S
J Alzheimers Dis; 2014; 41(2):633-40. PubMed ID: 24643135
[TBL] [Abstract][Full Text] [Related]
4. Orthostatic hypotension, balance and falls in Parkinson's disease.
Matinolli M; Korpelainen JT; Korpelainen R; Sotaniemi KA; Myllylä VV
Mov Disord; 2009 Apr; 24(5):745-51. PubMed ID: 19133666
[TBL] [Abstract][Full Text] [Related]
5. Old and new acetylcholinesterase inhibitors for Alzheimer's disease.
Galimberti D; Scarpini E
Expert Opin Investig Drugs; 2016 Oct; 25(10):1181-7. PubMed ID: 27459153
[TBL] [Abstract][Full Text] [Related]
6. Uncontrolled hypertension and orthostatic hypotension in relation to standing balance in elderly hypertensive patients.
Shen S; He T; Chu J; He J; Chen X
Clin Interv Aging; 2015; 10():897-906. PubMed ID: 26064042
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
Allan LM; Ballard CG; Burn DJ; Kenny RA
J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
[TBL] [Abstract][Full Text] [Related]
8. Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer's Disease.
Russo P; Kisialiou A; Moroni R; Prinzi G; Fini M
Curr Drug Targets; 2017; 18(10):1179-1190. PubMed ID: 26424395
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholinesterase inhibitors in Alzheimer's disease influence Zinc and Copper homeostasis.
Giacconi R; Giuli C; Casoli T; Balietti M; Costarelli L; Provinciali M; Basso A; Piacenza F; Postacchini D; Galeazzi R; Fattoretti P; Nisi L; Fabbietti P; Papa R; Malavolta M
J Trace Elem Med Biol; 2019 Sep; 55():58-63. PubMed ID: 31345366
[TBL] [Abstract][Full Text] [Related]
10. Group Balance Training Specifically Designed for Individuals With Alzheimer Disease: Impact on Berg Balance Scale, Timed Up and Go, Gait Speed, and Mini-Mental Status Examination.
Ries JD; Hutson J; Maralit LA; Brown MB
J Geriatr Phys Ther; 2015; 38(4):183-93. PubMed ID: 25621384
[TBL] [Abstract][Full Text] [Related]
11. Cortical oxygen supply during postural hypotension is further decreased in Alzheimer's disease, but unrelated to cholinesterase-inhibitor use.
van Beek AH; Sijbesma JC; Jansen RW; Rikkert MG; Claassen JA
J Alzheimers Dis; 2010; 21(2):519-26. PubMed ID: 20555135
[TBL] [Abstract][Full Text] [Related]
12. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
[TBL] [Abstract][Full Text] [Related]
13. Impact of ambulatory physiotherapy on motor abilities of elderly subjects with Alzheimer's disease.
Manckoundia P; Taroux M; Kubicki A; Mourey F
Geriatr Gerontol Int; 2014 Jan; 14(1):167-75. PubMed ID: 23617556
[TBL] [Abstract][Full Text] [Related]
14. Blood pro-inflammatory cytokines in Alzheimer's disease in relation to the use of acetylcholinesterase inhibitors.
Richardson C; Gard PR; Klugman A; Isaac M; Tabet N
Int J Geriatr Psychiatry; 2013 Dec; 28(12):1312-7. PubMed ID: 23585364
[TBL] [Abstract][Full Text] [Related]
15. Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer's disease: data from the French REAL.FR cohort.
Gillette-Guyonnet S; Cortes F; Cantet C; Vellas B;
J Nutr Health Aging; 2005; 9(2):69-73. PubMed ID: 15791348
[TBL] [Abstract][Full Text] [Related]
16. Donepezil improves gait performance in older adults with mild Alzheimer's disease: a phase II clinical trial.
Montero-Odasso M; Muir-Hunter SW; Oteng-Amoako A; Gopaul K; Islam A; Borrie M; Wells J; Speechley M
J Alzheimers Dis; 2015; 43(1):193-9. PubMed ID: 25079803
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment Ameliorate Acetaminophen-Induced Liver Injury in Mice via Central Cholinergic System Regulation.
Zhang J; Zhang L; Sun X; Yang Y; Kong L; Lu C; Lv G; Wang T; Wang H; Fu F
J Pharmacol Exp Ther; 2016 Nov; 359(2):374-382. PubMed ID: 27535978
[TBL] [Abstract][Full Text] [Related]
18. Cholinesterase inhibitors modulate autonomic function in patients with Alzheimer´s disease and mixed dementia.
da Costa Dias FL; Ferreira Lisboa da Silva RM; de Moraes EN; Caramelli P
Curr Alzheimer Res; 2013 Jun; 10(5):476-81. PubMed ID: 23627707
[TBL] [Abstract][Full Text] [Related]
19. Orthostatic hypotension and low blood pressure in organic dementia: a study of prevalence and related clinical characteristics.
Passant U; Warkentin S; Gustafson L
Int J Geriatr Psychiatry; 1997 Mar; 12(3):395-403. PubMed ID: 9152727
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant enzymatic activities in Alzheimer's disease: the relationship to acetylcholinesterase inhibitors.
Klugman A; Naughton DP; Isaac M; Shah I; Petroczi A; Tabet N
J Alzheimers Dis; 2012; 30(3):467-74. PubMed ID: 22451323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
